1. Cell Biology
  2. Microbiology and Infectious Disease

ADAM17-dependent signaling is required for oncogenic Human Papilloma virus entry platform assembly

  1. Snježana Mikuličić
  2. Jérôme Finke
  3. Fatima Boukhallouk
  4. Elena Wüstenhagen
  5. Dominik Sons
  6. Yahya Homsi
  7. Karina Reiss
  8. Thorsten Lang
  9. Luise Florin  Is a corresponding author
  1. University Medical Center of the Johannes Gutenberg University Mainz, Germany
  2. University of Bonn, Germany
  3. University Hospital Schleswig-Holstein Campus, Germany
https://doi.org/10.7554/eLife.44345
Share this article
Cite this article
  1. Snježana Mikuličić
  2. Jérôme Finke
  3. Fatima Boukhallouk
  4. Elena Wüstenhagen
  5. Dominik Sons
  6. Yahya Homsi
  7. Karina Reiss
  8. Thorsten Lang
  9. Luise Florin
(2019)
ADAM17-dependent signaling is required for oncogenic Human Papilloma virus entry platform assembly
eLife 8:e44345.
https://doi.org/10.7554/eLife.44345
  2. Download BibTeX
  3. Download .RIS

Abstract

Oncogenic Human papillomaviruses (HPV) are small DNA viruses that infect keratinocytes. After HPV binding to cell surface receptors a cascade of molecular interactions mediates the infectious cellular internalization of virus particles. Aside from the virus itself, important molecular players involved in virus entry include the tetraspanin CD151 and the epidermal growth factor receptor (EGFR). To date, it is unknown how these components are coordinated in space and time. Here, we studied plasma membrane dynamics of CD151 and EGFR and the HPV16 capsid during the early phase of infection. We find that the proteinase ADAM17 activates the extracellular signal regulated kinases (ERK1/2) pathway by the shedding of growth factors that trigger the formation of an endocytic entry platform. Infectious endocytic entry platforms carrying virus particles consist of two-fold larger CD151 domains containing the EGFR. Our finding clearly dissects initial virus binding from ADAM17-dependent assembly of a HPV/CD151/EGFR entry platform.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files.

Article and author information

Author details

  1. Snježana Mikuličić

    Institute for Virology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany
    Competing interests
    The authors declare that no competing interests exist.

  2. Jérôme Finke

    Department of Membrane Biochemistry, Life and Medical Sciences Institute, University of Bonn, Bonn, Germany
    Competing interests
    The authors declare that no competing interests exist.

  3. Fatima Boukhallouk

    Department of Medical Microbiology and Hygiene, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany
    Competing interests
    The authors declare that no competing interests exist.

  4. Elena Wüstenhagen

    Institute for Virology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5420-6536

  5. Dominik Sons

    Department of Membrane Biochemistry, Life and Medical Sciences Institute, University of Bonn, Bonn, Germany
    Competing interests
    The authors declare that no competing interests exist.

  6. Yahya Homsi

    Department of Membrane Biochemistry, Life and Medical Sciences Institute, University of Bonn, Bonn, Germany
    Competing interests
    The authors declare that no competing interests exist.

  7. Karina Reiss

    Department of Dermatology and Allergology, University Hospital Schleswig-Holstein Campus, Kiel, Germany
    Competing interests
    The authors declare that no competing interests exist.

  8. Thorsten Lang

    Department of Membrane Biochemistry, Life and Medical Sciences Institute, University of Bonn, Bonn, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9128-0137

  9. Luise Florin

    Institute for Virology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany
    For correspondence
    lflorin@uni-mainz.de
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4310-7329

Funding

Deutsche Forschungsgemeinschaft (FL 696/3-1)

  • Thorsten Lang
  • Luise Florin

Deutscher Akademischer Austauschdienst

  • Snježana Mikuličić

Deutsche Forschungsgemeinschaft (LA 1272/8-1)

  • Thorsten Lang
  • Luise Florin

Deutsche Forschungsgemeinschaft (CRC877 (A4))

  • Karina Reiss

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Pamela J Bjorkman, California Institute of Technology, United States

Version history

  1. Received: December 12, 2018
  2. Accepted: May 17, 2019
  3. Accepted Manuscript published: May 20, 2019 (version 1)
  4. Version of Record published: June 10, 2019 (version 2)

Copyright

© 2019, Mikuličić et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,043
    views
  • 284
    downloads
  • 24
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Snježana Mikuličić
  2. Jérôme Finke
  3. Fatima Boukhallouk
  4. Elena Wüstenhagen
  5. Dominik Sons
  6. Yahya Homsi
  7. Karina Reiss
  8. Thorsten Lang
  9. Luise Florin
(2019)
ADAM17-dependent signaling is required for oncogenic Human Papilloma virus entry platform assembly
eLife 8:e44345.
https://doi.org/10.7554/eLife.44345

Share this article

https://doi.org/10.7554/eLife.44345

Categories and tags

Research organism

Further reading

    1. Cell Biology

    A genome-wide CRISPR/Cas9 screen identifies calreticulin as a selective repressor of ATF6α

    Joanne Tung, Lei Huang ... Adriana Ordonez
    Research Article

    Activating transcription factor 6 (ATF6) is one of three endoplasmic reticulum (ER) transmembrane stress sensors that mediate the unfolded protein response (UPR). Despite its crucial role in long-term ER stress adaptation, regulation of ATF6 alpha (α) signalling remains poorly understood, possibly because its activation involves ER-to-Golgi and nuclear trafficking. Here, we generated an ATF6α/Inositol-requiring kinase 1 (IRE1) dual UPR reporter CHO-K1 cell line and performed an unbiased genome-wide CRISPR/Cas9 mutagenesis screen to systematically profile genetic factors that specifically contribute to ATF6α signalling in the presence and absence of ER stress. The screen identified both anticipated and new candidate genes that regulate ATF6α activation. Among these, calreticulin (CRT), a key ER luminal chaperone, selectively repressed ATF6α signalling: Cells lacking CRT constitutively activated a BiP::sfGFP ATF6α-dependent reporter, had higher BiP levels and an increased rate of trafficking and processing of ATF6α. Purified CRT interacted with the luminal domain of ATF6α in vitro and the two proteins co-immunoprecipitated from cell lysates. CRT depletion exposed a negative feedback loop implicating ATF6α in repressing IRE1 activity basally and overexpression of CRT reversed this repression. Our findings indicate that CRT, beyond its known role as a chaperone, also serves as an ER repressor of ATF6α to selectively regulate one arm of the UPR.

    1. Cancer Biology
    2. Cell Biology

    A syngeneic spontaneous zebrafish model of tp53-deficient, EGFRvIII, and PI3KCAH1047R-driven glioblastoma reveals inhibitory roles for inflammation during tumor initiation and relapse in vivo

    Alex Weiss, Cassandra D'Amata ... Madeline N Hayes
    Research Article

    High-throughput vertebrate animal model systems for the study of patient-specific biology and new therapeutic approaches for aggressive brain tumors are currently lacking, and new approaches are urgently needed. Therefore, to build a patient-relevant in vivo model of human glioblastoma, we expressed common oncogenic variants including activated human EGFRvIII and PI3KCAH1047R under the control of the radial glial-specific promoter her4.1 in syngeneic tp53 loss-of-function mutant zebrafish. Robust tumor formation was observed prior to 45 days of life, and tumors had a gene expression signature similar to human glioblastoma of the mesenchymal subtype, with a strong inflammatory component. Within early stage tumor lesions, and in an in vivo and endogenous tumor microenvironment, we visualized infiltration of phagocytic cells, as well as internalization of tumor cells by mpeg1.1:EGFP+ microglia/macrophages, suggesting negative regulatory pressure by pro-inflammatory cell types on tumor growth at early stages of glioblastoma initiation. Furthermore, CRISPR/Cas9-mediated gene targeting of master inflammatory transcription factors irf7 or irf8 led to increased tumor formation in the primary context, while suppression of phagocyte activity led to enhanced tumor cell engraftment following transplantation into otherwise immune-competent zebrafish hosts. Altogether, we developed a genetically relevant model of aggressive human glioblastoma and harnessed the unique advantages of zebrafish including live imaging, high-throughput genetic and chemical manipulations to highlight important tumor-suppressive roles for the innate immune system on glioblastoma initiation, with important future opportunities for therapeutic discovery and optimizations.

    1. Cancer Biology
    2. Cell Biology

    Cancer: Modeling glioblastoma

    Ian Lorimer
    Insight

    Establishing a zebrafish model of a deadly type of brain tumor highlights the role of the immune system in the early stages of the disease.